541 related articles for article (PubMed ID: 14716182)
1. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women.
Capobianco G; Donolo E; Borghero G; Dessole F; Cherchi PL; Dessole S
Arch Gynecol Obstet; 2012 Feb; 285(2):397-403. PubMed ID: 21706345
[TBL] [Abstract][Full Text] [Related]
3. Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women.
Capobianco G; Wenger JM; Meloni GB; Dessole M; Cherchi PL; Dessole S
Arch Gynecol Obstet; 2014 Mar; 289(3):601-8. PubMed ID: 24057079
[TBL] [Abstract][Full Text] [Related]
4. Are all estrogens created equal?
Eckler K
Menopause; 2004; 11(1):7-8. PubMed ID: 14716177
[No Abstract] [Full Text] [Related]
5. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
[TBL] [Abstract][Full Text] [Related]
6. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
[TBL] [Abstract][Full Text] [Related]
8. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
Raz R; Stamm WE
N Engl J Med; 1993 Sep; 329(11):753-6. PubMed ID: 8350884
[TBL] [Abstract][Full Text] [Related]
9. Effect of oral estriol on urogenital symptoms, vaginal cytology, and plasma hormone level in postmenopausal women.
Manonai J; Theppisai U
J Med Assoc Thai; 2001 Apr; 84(4):539-44. PubMed ID: 11460966
[TBL] [Abstract][Full Text] [Related]
10. [Long-term use of ovestin by postmenopausal women with urinary incontinence].
D'iakov VV; Godunov BN; Gvozdev MIu
Urologiia; 2003; (1):43-6. PubMed ID: 12621967
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
Archer DF
Menopause; 2010; 17(1):194-203. PubMed ID: 19602990
[TBL] [Abstract][Full Text] [Related]
12. [Vaginal estriol administration in treatment of postmenopausal urinary incontinence].
Schmidbauer CP
Urologe A; 1992 Nov; 31(6):384-9. PubMed ID: 1462489
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women.
Raz R; Colodner R; Rohana Y; Battino S; Rottensterich E; Wasser I; Stamm W
Clin Infect Dis; 2003 Jun; 36(11):1362-8. PubMed ID: 12766829
[TBL] [Abstract][Full Text] [Related]
15. Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women.
Iosif CS
Arch Gynecol Obstet; 1992; 251(3):115-20. PubMed ID: 1605675
[TBL] [Abstract][Full Text] [Related]
16. [Topical hormonal treatment and urogenital atrophy].
Sitruk-Ware R; Thomas JL
Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
[TBL] [Abstract][Full Text] [Related]
17. [Effect of local estriol therapy on the urethral pressure profile in the postmenopausal period].
Hajdu K; Festge OA; Gross W; Rosenbaum KD
Zentralbl Gynakol; 1986; 108(22):1370-8. PubMed ID: 3825332
[TBL] [Abstract][Full Text] [Related]
18. Vaginal estrogen therapy and overactive bladder symptoms in postmenopausal patients after a tension-free vaginal tape procedure: a randomized clinical trial.
Zullo MA; Plotti F; Calcagno M; Palaia I; Muzii L; Manci N; Angioli R; Panici PB
Menopause; 2005; 12(4):421-7. PubMed ID: 16037757
[TBL] [Abstract][Full Text] [Related]
19. Effect of raloxifene on sexual function in postmenopausal women.
Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
[TBL] [Abstract][Full Text] [Related]
20. Estrogen therapy in older patients with recurrent urinary tract infections: a review.
Rozenberg S; Pastijn A; Gevers R; Murillo D
Int J Fertil Womens Med; 2004; 49(2):71-4. PubMed ID: 15188831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
